back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-01 14:39 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,000
+5,000 vol $5.60 each |
81,780 | |
| Filed 2022-06-01 14:25 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,186
+822 vol $2.66 each |
76,780 | |
| Filed 2022-06-01 14:24 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$35,279
+22,870 vol $1.54 each |
75,958 | |
| Filed 2022-06-01 14:24 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$69,528
+45,072 vol $1.54 each |
53,088 | |
| Filed 2022-06-01 14:23 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,954
+8,016 vol $1.12 each |
8,016 | |
| Filed 2022-06-01 14:23 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,186.2734
-822 vol $2.66 each |
21,776 | |
| Filed 2022-06-01 14:22 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-35,279.262
-22,870 vol $1.54 each |
22,598 | |
| Filed 2022-06-01 14:21 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-69,528.0672
-45,072 vol $1.54 each |
45,468 | |
| Filed 2022-06-01 14:21 Tx date 2022-05-31 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,954.6736
-8,016 vol $1.12 each |
90,540 | |
| Filed 2020-06-08 16:24 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
98,556 | |
| Filed 2019-11-15 14:55 Tx date 2019-11-12 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,000 vol |
83,556 | |
| Filed 2019-05-22 16:31 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
79,556 | ||
| Filed 2019-05-22 16:30 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Truex, Paul Francis
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|